Sun Pharmaceutical Industries gets High Court approval for merger scheme

Image
Capital Market
Last Updated : Nov 24 2014 | 5:15 PM IST

Order put on High Court website on 21 November 2014

Sun Pharmaceutical Industries announced that the Hon'ble High Court of Gujarat at Ahmedabad, at its hearing held on 14 November 2014, has sanctioned the Scheme of Arrangement in the nature of Merger of Ranbaxy Laboratories with Sun Pharmaceutical Industries pursuant to its oral order uploaded on the web site of Hon'ble High Court of Gujarat on 21 November 2014.

Further the Company has informed that the said Scheme of Arrangement will be effective on receipt of the order / approval from Hon'ble High Court of Punjab and Haryana Competition Commission of India, Foreign Investment Promotion Board and other approvals as may be required and on filing of a copy of the order of Hon'ble High Courts with the respective Registrars of Companies.

Powered by Capital Market - Live News

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 24 2014 | 3:48 PM IST

Next Story